Smoking is associated with adverse clinical outcomes in patients undergoing revascularization with PCI or CABG: the SYNTAX trial at 5-year follow-up.

@article{Zhang2015SmokingIA,
  title={Smoking is associated with adverse clinical outcomes in patients undergoing revascularization with PCI or CABG: the SYNTAX trial at 5-year follow-up.},
  author={Yaojun Zhang and Javaid Iqbal and David van Klaveren and Carlos M Campos and David R. Holmes and Arie Pieter Kappetein and Marie-claude Morice and Adrian P. Banning and Ever D. Grech and Christos V. Bourantas and Yoshinobu Onuma and H. M. Garcia-Garcia and Michael J. Mack and Antonio Colombo and Friedrich W. Mohr and Ewout Willem Steyerberg and Patrick W Serruys},
  journal={Journal of the American College of Cardiology},
  year={2015},
  volume={65 11},
  pages={1107-15}
}
BACKGROUND Cigarette smoking is a well-known risk factor for development of coronary artery disease (CAD). However, some studies have suggested a "smoker's paradox," meaning neutral or favorable outcomes in smokers who have developed CAD, especially myocardial infarction (MI). OBJECTIVES The study aimed to examine the association of smoking status with clinical outcomes in the randomized controlled SYNTAX (SYNergy Between PCI With TAXUS and Cardiac Surgery) trial at 5-year follow-up… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 13 times over the past 90 days. VIEW TWEETS
14 Citations
36 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 36 references

Lifeyears gained by smoking cessation after percutaneous coronary intervention

  • SP de Boer, PW Serruys, G Valstar
  • Am J Cardiol
  • 2013

Similar Papers

Loading similar papers…